TY - JOUR
T1 - Predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019
T2 - A systematic review and meta-analysis
AU - Duarsa, Gede Wirya Kusuma
AU - Sugianto, Ronald
AU - Yusari, I. Gusti Agung Ayu Andra
AU - Tirtayasa, Pande Made Wisnu
AU - Situmorang, Gerhard Reinaldi
AU - Rasyid, Nur
AU - Rodjani, Arry
AU - Daryanto, Besut
AU - Seputra, Kurnia Penta
AU - Satyagraha, Paksi
N1 - Funding Information:
None.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2023/2
Y1 - 2023/2
N2 - Introduction: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a massive impact on the health sector, especially in patients with pre-existing comorbidities. This study aims to define the predictor factors for worse outcomes in kidney transplant patients infected with SARS-CoV-2 and affected by coronavirus disease 2019 (COVID-19). We have analyzed in these patients their prior medical history, their clinical symptoms, and their laboratory results. Method: We assessed outcomes of kidney transplant patients with confirmed COVID-19 until July 2021 from PubMed, Medline, Science Direct, Cochrane databases, EMBASE, Scopus, and EBSCO. We performed meta-analyses of nine published studies to estimate predictor factors. The analysis was analyzed by the Newcastle-Ottawa Scale (NOS) and then using the Review Manager 5.4 software. Result: Our analysis demonstrated that the most significant risk factors for the worse COVID-19 outcomes for kidney transplant patients included: age of 60 and older [MD 9.31(95% CI, 6.31–12.30), p < 0.0001, I2 = 76%], diabetic nephropathy [OR 2.13 (95% CI, 1.49–3.04), p < 0.0001, I2 = 76%], dyspnea [OR 4.53, (95% CI, 2.22–9.22), p < 0.0001, I2 = 76%], acute kidney injury (AKI) [OR 4.53 (95% CI, 1.10–5.21), p = 0.03, I2 = 58%], and some laboratory markers. Many patients had two or multiple risk factors in combination. Conclusion: Age and several comorbidities were the most significant factors for COVID-19 outcomes for kidney transplant recipients.
AB - Introduction: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a massive impact on the health sector, especially in patients with pre-existing comorbidities. This study aims to define the predictor factors for worse outcomes in kidney transplant patients infected with SARS-CoV-2 and affected by coronavirus disease 2019 (COVID-19). We have analyzed in these patients their prior medical history, their clinical symptoms, and their laboratory results. Method: We assessed outcomes of kidney transplant patients with confirmed COVID-19 until July 2021 from PubMed, Medline, Science Direct, Cochrane databases, EMBASE, Scopus, and EBSCO. We performed meta-analyses of nine published studies to estimate predictor factors. The analysis was analyzed by the Newcastle-Ottawa Scale (NOS) and then using the Review Manager 5.4 software. Result: Our analysis demonstrated that the most significant risk factors for the worse COVID-19 outcomes for kidney transplant patients included: age of 60 and older [MD 9.31(95% CI, 6.31–12.30), p < 0.0001, I2 = 76%], diabetic nephropathy [OR 2.13 (95% CI, 1.49–3.04), p < 0.0001, I2 = 76%], dyspnea [OR 4.53, (95% CI, 2.22–9.22), p < 0.0001, I2 = 76%], acute kidney injury (AKI) [OR 4.53 (95% CI, 1.10–5.21), p = 0.03, I2 = 58%], and some laboratory markers. Many patients had two or multiple risk factors in combination. Conclusion: Age and several comorbidities were the most significant factors for COVID-19 outcomes for kidney transplant recipients.
KW - COVID-19
KW - Kidney transplant
KW - Meta-analysis
KW - Outcome
KW - Risk factor
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85142769223&partnerID=8YFLogxK
U2 - 10.1016/j.trim.2022.101739
DO - 10.1016/j.trim.2022.101739
M3 - Review article
C2 - 36414181
AN - SCOPUS:85142769223
SN - 0966-3274
VL - 76
JO - Transplant Immunology
JF - Transplant Immunology
M1 - 101739
ER -